ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,990.68
0.07%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Neuropace Inc (NPCE)

  7. Neuropace Inc (NPCE) Noticias

NPCE

Neuropace (NPCE)

Neuropace Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NPCE
FechaHoraFuenteTítuloSímboloCompañía
08/05/202416:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NPCENeuropace Inc
08/05/202415:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NPCENeuropace Inc
05/03/202416:48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NPCENeuropace Inc
28/02/202419:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NPCENeuropace Inc
14/02/202415:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NPCENeuropace Inc
20/12/202316:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NPCENeuropace Inc
19/07/202315:46Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NPCENeuropace Inc
28/06/202315:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NPCENeuropace Inc
14/06/202316:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NPCENeuropace Inc
04/05/202315:05GlobeNewswire Inc.NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue GuidanceNASDAQ:NPCENeuropace Inc
25/04/202316:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NPCENeuropace Inc
25/04/202316:28Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NPCENeuropace Inc
17/04/202315:05GlobeNewswire Inc.NeuroPace to Report First Quarter 2023 Financial Results on May 4, 2023NASDAQ:NPCENeuropace Inc
03/04/202315:05GlobeNewswire Inc.NeuroPace to Present at the 22nd Annual Needham Virtual Healthcare ConferenceNASDAQ:NPCENeuropace Inc
02/03/202316:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NPCENeuropace Inc
02/03/202315:05GlobeNewswire Inc.NeuroPace Reports Fourth Quarter & Full Year 2022 Financial ResultsNASDAQ:NPCENeuropace Inc
14/02/202316:14Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NPCENeuropace Inc
10/02/202312:13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NPCENeuropace Inc
10/02/202307:00GlobeNewswire Inc.NeuroPace to Report Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023NASDAQ:NPCENeuropace Inc
09/01/202315:29Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NPCENeuropace Inc
09/01/202315:03GlobeNewswire Inc.NeuroPace Announces Preliminary Unaudited Fourth Quarter and Full-Year 2022 Revenue and Appoints Dr. Uri Geiger to Board of DirectorsNASDAQ:NPCENeuropace Inc
21/12/202215:03GlobeNewswire Inc.NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare ConferenceNASDAQ:NPCENeuropace Inc
30/11/202207:00Business WireNeuroPace Feasibility Study of Its RNS System for Lennox-Gastaut Syndrome Now UnderwayNASDAQ:NPCENeuropace Inc
23/11/202216:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:NPCENeuropace Inc
21/11/202206:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NPCENeuropace Inc
08/11/202215:29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NPCENeuropace Inc
08/11/202215:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NPCENeuropace Inc
08/11/202215:03GlobeNewswire Inc.NeuroPace Reports Third Quarter 2022 Financial Results and Provides a Business UpdateNASDAQ:NPCENeuropace Inc
04/11/202215:03GlobeNewswire Inc.NeuroPace to Present at the 4th Annual Wolfe Research Healthcare ConferenceNASDAQ:NPCENeuropace Inc
25/10/202215:03GlobeNewswire Inc.NeuroPace to Report Third Quarter 2022 Financial Results on November 8, 2022NASDAQ:NPCENeuropace Inc
 Showing the most relevant articles for your search:NASDAQ:NPCE

Su Consulta Reciente

LSE
47TL
Res Mtg 13 Nt36
COIN
WTPBTC
COIN
EMPIREUST
Empire Token
BIT
UC92RX
Unicredit Bank
ASX
YOJN
Yojee
LSE
95KT
Barclays 26
ASX
XALG
Fidante Partners
GATE
GOBUSDT
Goons of Balatroon
TSX
BCE.PR.Z
BCE
EU
5327S
5327S
NASDAQ
CUR
Neuralstem
COIN
CFIUSD
CyberFi Token
LSE
102G
LSE
CMIB
Ishr Ftse Mib A
COIN
MOBICGBP
Mobility Coin
LSE
TK06
Hsbc Bk.24
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados